Carotid Stent System Market Report 2024 (Global Edition)

Global Carotid Stent System Market Report 2024 Market Size Split by Type (Balloon expandable stents, Self-expanding stents), by Application (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Ot...

Carotid Stent System Market Report Description

We have various report editions of Carotid Stent System Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Carotid Stent System Market Insights Video

Competitive Landscape of the Carotid Stent System Market

The market for carotid stent systems is competitive, and leading companies are concentrating on technological advancements such as flexible and drug-eluting stents to improve efficacy and safety. Important businesses like Abbott, Medtronic, and Boston Scientific make investments in product development, research, and strategic alliances to improve their market positions. As businesses strive to satisfy growing demand and broaden their market reach, other factors that impact competition include product quality, regulatory approvals, and international development initiatives.

In March 2024, The iCast® covered stent system, which was recently approved for use in treating symptomatic iliac arterial occlusive disease, has an exclusive sales and distribution agreement between Getinge and Cook Medical. (Source:https://www.cookmedical.com/newsroom/getinge-and-cook-medical-enter-into-commercial-distribution-agreement-for-icast-covered-stent-system-in-the-united-states/) In October 2022, MedAlliance, a Swiss manufacturer of cutting-edge drug-eluting balloons, was acquired by Cordis. Through this acquisition, Cordis will have access to the drug-eluting balloon SOLUTION SLR (Sustained Limus Release), which might treat two million patients globally by 2027. (Source: https://cordis.com/na/news/new-press-release) In August 2022, Medtronic introduced its newest drug-eluting coronary stent, the Onyx Frontier. The Onyx Frontier DES offers a new delivery method and is based on the clinical data and acute performance of the Resolute Onyx drug-eluting stent. The DES has an enhanced delivery method designed to boost acute performance and enhance deliverability in the most challenging patients. It utilizes the same stent platform as Resolute Onyx DES. (Source:https://news.medtronic.com/Medtronic-launches-latest-generation-drug-eluting-coronary-stent-system-following-CE-Mark-approval) In March 2022, Terumo Aortic announced that the RelayBranch Thoracic Stent-Graft System had received Breakthrough Device Designation from the US Food and Drug Administration (FDA). The system treats patients with thoracic aortic arch diseases who need therapy that covers the left common carotid artery and innominate artery. (Source: https://www.terumo.com/newsrelease/detail/20220318/684) In June 2021, MicroVention Europe and Terumo France/Europe are pleased that the RoadsaverTM carotid stent system has been reimbursed. This significant outcome comes after the French National Authority for Health (HAS) gave the device a positive evaluation, highlighting its therapeutic benefits. (Source: https://www.terumo.com/newsrelease/detail/20210629/620) In October 2020, The FDA granted Cook Medical premarket clearance (PMA) for the Zilver Vena in the United States. Iliofemoral venous disease is treated with the Zilver Vena stent. The stent was created with strength and flexibility in mind, making sure it fits the anatomy of the patient while also growing sufficiently to reconnect veins. (Source:https://www.cookmedical.com/newsroom/zilver-vena-fda-approval/)

Top Companies Market Share in Carotid Stent System Industry: (In no particular order of Rank)

• L. Gore & Associates
• Terumo Corporation
• InspireMD
• Medtronic
• Abbott
• Cook Medical
• Cordis (Cardinal Health)
• MicroPort Scientific Corporation.
• Boston Scientific Corporation
• CeloNova BioSciences
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Carotid Stent System Market

Which Region Dominates the Carotid Stent System Market in 2024?

According to Cognitive Market Research, North America currently dominates the Carotid Stent System market, and the region is expected to have significant growth during the projected period. Because of the high prevalence of cardiovascular illnesses, sophisticated healthcare system, and widespread use of minimally invasive procedures, North America is anticipated to propel the market for carotid stent systems. Another factor driving up demand for carotid stenting is the ageing population and growing knowledge of stroke prevention. Additionally, the existence of major market players like Abbott and Medtronic, advantageous reimbursement regulations, and technological developments in stent design all assist market expansion. Because of its well-established healthcare system and emphasis on innovative medical treatments, North America is a key location for the expansion of carotid stent systems.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Because of the increasing prevalence of cardiovascular disease, improved medical infrastructure, and easier access to healthcare, Asia Pacific is expected to propel the carotid stent system market to significant growth. Carotid stenting and other modern stroke prevention procedures are in high demand due to the region's ageing population and increasing urbanization. Additionally, market acceptance is being fueled by a shift toward minimally invasive procedures and growing healthcare costs. A major growth driver for the carotid stent system market is Asia Pacific, which is further supported by government attempts to improve healthcare facilities and growing awareness of stroke risk in nations like China, India, and Japan.

The current report Scope analyzes Carotid Stent System Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Carotid Stent System

According to Cognitive Market Research, the global Carotid Stent System market size was estimated at USD 1851.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 740.60 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Carotid Stent System market with a market size of USD 584.33 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. The United States is a leader in the use of carotid stenting because it has access to cutting-edge medical technology and highly qualified medical personnel.
• The Canadian Carotid Stent System market had a market share of USD 88.87 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. Canada's strong public healthcare system facilitates the extensive use of carotid stenting.
• The Mexico Carotid Stent System market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 67.39 million in 2024.

Europe Carotid Stent System

According to Cognitive Market Research, the global Carotid Stent System market size was estimated at USD 1851.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 555.45 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• The United Kingdom Carotid Stent System market had a market share of USD 93.32 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Because of the UK government's emphasis on stroke prevention initiatives, carotid stenting is becoming more widely used.
• The France Carotid Stent System market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 51.10 million in 2024.
• According to Cognitive Market Research, the German Carotid Stent System market size was valued at USD 109.98 million in 2024 and is projected to grow at a CAGR of 10.2% during the forecast period. Germany is a leader in the use of cutting-edge medical technologies, such as carotid stenting and other minimally invasive techniques.
• The Italy Carotid Stent System market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 47.77 million in 2024.
• The Russia Carotid Stent System market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 86.09 million in 2024.
• The Spain Carotid Stent System market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 45.55 million in 2024
• The Luxembourg Carotid Stent System market is projected to witness growth at a CAGR of 10.1% during the forecast period, with a market size of USD 17.22 million in 2024.
• The Portugal Carotid Stent System market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 11.66 million in 2024.
• The Greece Carotid Stent System market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 6.67 million in 2024.
• The Rest of Europe's Carotid Stent System market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 86.09 million in 2024.

Asia Pacific Carotid Stent System

According to Cognitive Market Research, the global Carotid Stent System market size was estimated at USD 1851.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 425.85 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Carotid Stent System market size was valued at USD 191.63 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period. Carotid Stent System has surged in China due to the country's ageing population, unhealthy lifestyles, and fast urbanization; cardiovascular illnesses are on the rise in China..
• The Japan Carotid Stent System market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 58.77 million in 2024.
• The India Carotid Stent System market had a market share of USD 51.10 million in 2024 and is projected to grow at a CAGR of 15.3% during the forecast period. In India, advanced medical technology, such as carotid stent systems, is becoming more accessible because of government programs and private-sector investments.
• The South Korean Carotid Stent System market is projected to witness growth at a CAGR of 12.6% during the forecast period, with a market size of USD 42.58 million in 2024.
• The Australian Carotid Stent System market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 22.14 million in 2024.
• The South East Asia Carotid Stent System market is projected to witness growth at a CAGR of 14.5% during the forecast period, with a market size of USD 29.38 million in 2024.
• The Rest of Asia Pacific Carotid Stent System market is projected to witness growth at a CAGR of 13.3% during the forecast period, with a market size of USD 30.23 million in 2024.

South America Carotid Stent System

According to Cognitive Market Research, the global Carotid Stent System market size was estimated at USD 1851.5 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 92.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Carotid Stent System market size was valued at USD 39.62 million in 2024 and is projected to grow at a CAGR of 11.5% during the forecast period. Carotid Stent System flourished in Brazil due to the need for carotid stenting is increasing because of a growth in chronic diseases, including diabetes and hypertension.
• Argentina's Carotid Stent System market had a market share of USD 15.55 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. In Argentina, the need for carotid stenting as a preventative measure is being driven by the rising incidence of coronary illnesses.
• Colombia's Carotid Stent System market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 8.24 million in 2024.
• Peru's Carotid Stent System market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 7.59 million in 2024.
• Chile's Carotid Stent System market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 6.67 million in 2024.
• The Rest of Latin America's Carotid Stent System market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 14.90 million in 2024.

Middle East and Africa Carotid Stent System

According to Cognitive Market Research, the global Carotid Stent System market size was estimated at USD 1851.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 37.03 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.2% from 2024 to 2031..

• The GCC Countries Carotid Stent System market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 15.85 million in 2024. Carotid Stent System sales flourish in GCC countries due to the increasing collaboration between healthcare providers and medical device companies.
• The Egypt Carotid Stent System market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 3.89 million in 2024.
• The South African Carotid Stent System market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 5.85 million in 2024. Carotid Stent System sales flourished in South Africa due to increased disposable income and demand for premium healthcare services.
• The Turkey Carotid Stent System market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 3.18 million in 2024.
• The Nigeria Carotid Stent System market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 3.89 million in 2024.
• The Rest of the MEA Carotid Stent System market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 4.37 million in 2024.

Carotid Stent System Market Analysis

Carotid Stent System Market Type Segment Analysis

According to Cognitive Market Research, balloon expandable stents are likely to dominate the Carotid Stent System Market over the forecast period. Due to their capacity to provide accurate deployment and efficient treatment for carotid artery stenosis, balloon-expandable stents are becoming more and more popular in the carotid stent system market. A balloon catheter is used to extend these stents, which are composed of stainless steel or other sturdy materials, in order to widen the artery. Its adaptability, simplicity of usage, and efficacy in treating high-risk patients are the main reasons for its appeal. The demand for balloon-expandable stents is high in both established and emerging economies due to their predictable results, which improve blood flow and lower the risk of stroke.

Self-expanding stents are the fastest-growing segment in the Carotid Stent System Market. Self-expanding stents are becoming more and more popular in the carotid stent system market because of their capacity to automatically enlarge and adjust to the size of the artery, guaranteeing proper deployment with little assistance from the operator. Usually composed of materials like nitinol, these stents provide more flexibility and ease of use in narrow or twisted arteries, which makes them perfect for situations of complicated carotid artery stenosis. Their high deployment success rate and lower risk of problems have boosted adoption, especially among patients with difficult anatomical conditions, which has fueled market expansion.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Carotid Stent System Industry. Request a Free Sample PDF!

Carotid Stent System Market Application Segment Analysis

According to Cognitive Market Research, the hospital segment holds the largest share of the market. Because hospitals are the primary centres for the diagnosis and treatment of carotid artery stenosis, their use in the carotid stent system market is a major growth driver. Hospitals with highly qualified medical staff and state-of-the-art facilities perform carotid stenting treatments to lower the risk of stroke in patients with significant arterial narrowing. Hospitals are a significant component in the market's expansion due to the growing prevalence of cardiovascular illnesses, increased awareness of stroke prevention, and advancements in minimally invasive procedures, which are driving the need for carotid stent systems in hospitals.

In the Carotid Stent System Market, ambulatory surgical centres have been expanding at a rapid pace. The increase in the use of ambulatory surgical centres (ASCs) in the carotid stent system market is being driven by the increasing demand for less invasive procedures and more reasonably priced treatment options. ASCs provide patients having carotid stenting with a more convenient setting with quicker recovery times and reduced hospitalization costs than traditional hospitals. The demand for stent systems is rising as a result of the growing popularity of ASCs as a treatment option for carotid artery stenosis due to technological advancements and the growing utilization of same-day discharge procedures. This trend demonstrates the shift toward outpatient care in the cardiovascular industry.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Carotid Stent System Material Segment Analysis

Carotid Stent System Market Material Segment Analysis

According to Cognitive Market Research, the metals segment holds the largest share of the market. The need for stents that are biocompatible, flexible, and long-lasting is what is driving the market for metal materials in carotid stent systems. Because of their strength, flexibility, and corrosion resistance, materials, including cobalt-chromium alloys, stainless steel, and nitinol, are frequently utilized to ensure long-term functionality and safety within the body. Because of its self-expanding qualities, nitinol, in particular, is preferred for carotid stenting treatments. The usage of these advanced metal materials in stent systems is still being driven by the need for high-performance stents and the increasing demand for minimally invasive therapies.

In the Carotid Stent System Market, polymers have been expanding at a rapid pace. Because polymer materials improve stent efficacy, especially in drug-eluting stents, there is a growing need for them in the carotid stent system market. Stents are coated with polymers to administer therapeutic medications that assist in stopping restenosis or re-narrowing of the arteries. Biocompatible polymers, such as polyethylene and polyurethane, are preferred because they can minimize negative reactions while promoting tissue recovery. By lowering problems and increasing the effectiveness of stent systems, the use of polymers in stent coatings enhances patient outcomes and fuels the market's rising demand for stent systems.

• Metals
• Polymers
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion